Related Experiment Video
Updated: Mar 28, 2026

04:53
Zebrafish Larvae as a Model to Evaluate Potential Radiosensitizers or Protectors
Published on: August 25, 2022
2.2K
Anty radiation means: classification and mechanisms
1R. E. Kavetsky Institute of Experimental pathology, oncology and Radiobiology of NAS of Ukraine,45 Vasylkivska str., Kyiv, 03022, Ukraine.
Problemy Radiatsiinoi Medytsyny Ta Radiobiolohii
|December 24, 2015
Summary
This study reviews anti-radiation agents, focusing on radioprotectors, radiomitigators, and radio modulators. Novel approaches like purine and organoselenium compounds show promise for mitigating radiation damage, especially in prolonged low-dose exposures.
Area of Science:
- Radiation biology
- Pharmacology
- Toxicology
Background:
- Traditional radioprotectors often exhibit high toxicity, limiting their efficacy during prolonged, low-dose radiation exposure.
- A need exists for advanced anti-radiation agents with improved safety and effectiveness profiles.
- Understanding the mechanisms of action of radiation countermeasures is crucial for developing better protective strategies.
Purpose of the Study:
- To analyze and summarize the literature on the mechanisms of action of anti-radiation agents.
- To review the classification of modern anti-radiation agents, including radioprotectors, radiomitigators, and radio modulators.
- To explore novel preventative measures and radioprotective drugs that activate cellular repair systems.
Main Methods:
- Literature review and analysis of existing research on anti-radiation agents.
- Examination of purine and organoselenium compounds as potential preventative measures.
- Study of radioprotective drugs using human peripheral blood lymphocytes and chromosome aberration analysis as biomarkers of radiation damage.
Main Results:
- Many conventional radioprotectors are ineffective and toxic under prolonged low-dose radiation exposure.
- Purine derivatives and organoselenium compounds are identified as promising candidates for radiation protection.
- Radioprotective drugs that activate DNA repair systems show potential, particularly when assessed via chromosome aberration analysis in lymphocytes.
Conclusions:
- Novel anti-radiation agents, including purine and organoselenium compounds, offer potential advantages over traditional radioprotectors.
- Drugs activating repair systems, evaluated through chromosome aberration analysis, are recommended for specific high-risk populations.
- Further research into these advanced agents is warranted for effective management of radiation-induced risks.
Related Concept Videos
Biological Effects of Radiation
19.6K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
19.6K
Types of Radioactivity
21.3K
The most common types of radioactivity are α decay, β decay, γ decay, neutron emission, and electron capture.
Alpha (α) decay is the emission of an α particle from the nucleus. For example, polonium-210 undergoes α decay:
Alpha (α) decay is the emission of an α particle from the nucleus. For example, polonium-210 undergoes α decay:
21.3K
Mutations
45.5K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
45.5K
Mutations
96.4K
Overview
96.4K
Mutagenicity and Carcinogenicity
2.1K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.1K
Isotopes and Radioisotopes
13.8K
In the early 1900s, English chemist Frederick Soddy realized that an element could have atoms with different masses that were chemically indistinguishable. These different types are called isotopes — atoms of the same element that differ in mass. Isotopes differ in mass because they have different numbers of neutrons but are chemically identical because they have the same number of protons. Soddy was awarded the Nobel Prize in Chemistry in 1921 for this discovery.
An isotope containing...
An isotope containing...
13.8K

